D. B. Brunner

True versus immunoreactive angiotensin II in human plasma.

J. Nussberger, D. B. Brunner, Bernard Waeber et al. · Hypertension · 1985 · 187 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +19

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

Jérôme Biollaz, Michel Burnier, G. A. Turini et al. · Clinical Pharmacology & Therapeutics · 1981 · 147 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +16

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.

Bernard Waeber, H R Brunner, D. B. Brunner et al. · Hypertension · 1980 · 145 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +16

Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.

J. Nussberger, D. B. Brunner, Bernard Waeber et al. · Hypertension · 1986 · 134 citations

Hypertension, Cardiovascular Pharmacology, Bioanalysis +17

Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.

J. Nussberger, T. Fasanella D'amore, M Porchet et al. · PubMed · 1987 · 128 citations

Molecular Pharmacology, Hypertension, Inhibitory Activity +15